Analgesics
Antiandrogens
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Abstract
All ivermectin studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19ivm.org COVID-19 treatment researchIvermectinIvermectin (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   

Ivermectin in Long-Covid Patients: A Retrospective Study

Del Franco et al., Journal of Biomedical Research and Clinical Investigation, doi:10.31546/2633-8653.1008
Mar 2021  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Ivermectin for COVID-19
4th treatment shown to reduce risk in August 2020
 
*, now known with p < 0.00000000001 from 103 studies, recognized in 22 countries.
No treatment is 100% effective. Protocols combine complementary and synergistic treatments. * >10% efficacy in meta analysis with ≥3 clinical studies.
4,100+ studies for 60+ treatments. c19ivm.org
Retrospective 856 patients previously admitted to hospital for COVID-19 in Argentina, finding that ivermectin improved recovery from "long covid" symptoms.
Del Franco et al., 18 Mar 2021, peer-reviewed, 3 authors.
This PaperIvermectinAll
Ivermectin IN Long-Covid Patients: A Retrospective Study
Delfranco Haroldo, Hirsch Roberto, Carvallo Hector
Journal of Biomedical Research and Clinical Investigation, doi:10.31546/2633-8653.1008
Long COVID convalescence has become a major issue in COVID infection. The variety and magnitude of sequelae has, so far, baffled scientific community, and no measure has proved to be both useful and reliable in diminishing and/or shortening it. We are summarising the outcomes in 856 patients previously admitted at a Public Hospital in the Province of Buenos Aires, due to moderate/severe COVID infection, who surmounted the infection and could be released later on. We selected those whose symptoms, and mainly, the duration of them-could be attributed to long convalescence (long haulers). In them, a simple post-COVID treatment with ivermectin (IVM) was applied, thus provoking a faster reduction of manifestations.
Conflicts of Interest: The authors declare no conflict of interest.
References
Aaron, Treating Post-COVID Fatigue and Dyspnea; Deep Breaths and Plenty of Rest, Medscape
Alonso, Bracho, Wilmer, Ivermectin in Covid-19 patients: a multicenter, retrospective study
Carvallo, Hirsch, Farinella, Safety and efficacy of the combined use of ivermectin, dexamethasone, enoxaparin and aspirin against covid 19, doi:10.1101/2020.09.10.20191619v1.full.pdf
Carvallo, Matozza, Hirsch, Covid Pandemic and Repurposed Drugs: How much is a human life? Researchgate
George, Study Puts Numbers to 'Long COVID' Duration, Prevalence, MedPage Today
Héctor, Roberto, Psaltis, Veronica, Study of the Efficacy and Safety of Topical Ivermectin + IotaCarrageenan in the Prophylaxis against COVID-19 in Health Personnel, J Biomed Res Clin Investig
Long, Haulers: Symptoms and Connections to Post Viral Fatigue and Organ Damage, Practical Pain Management
Mannan, Deleterious Outcomes in Long-Hauler COVID-19: The Effects of SARS-CoV-2 on the CNS in Chronic COVID Syndrome, ACS Chem Neurosci, doi:10.1021/acschemneuro.0c00725
Monica, Long-term follow-up of recovered patients with COVID-19, Lancet
Nisreen, A negative COVID-19 test does not mean recovery, Nature
Roberto, Hector, Covid 19 and Ivermectin Prevention and Treatment Update, Inf Dis Trav Med
Rubin, As Their Numbers Grow, COVID-19 "Long Haulers" Stump Experts, JAMA
Townsend, Kate, Brien, Persistent Poor Health Post-COVID-19 Is Not Associated with Respiratory Complications or Initial Disease Severity, Ann Am Thorac Soc
Uc, Health, Long haulers: Why some people experience long-term coronavirus symptoms
Venkatesan, NICE guideline on long COVID, Lancet Respir Med
{ 'DOI': '10.31546/2633-8653.1008', 'ISSN': ['2633-8653', '2633-8653'], 'URL': 'http://dx.doi.org/10.31546/2633-8653.1008', 'author': [ {'affiliation': [], 'family': 'Haroldo', 'given': 'DelFranco', 'sequence': 'first'}, {'affiliation': [], 'family': 'Roberto', 'given': 'Hirsch', 'sequence': 'additional'}, {'affiliation': [], 'family': 'Hector', 'given': 'Carvallo', 'sequence': 'additional'}], 'container-title': 'Journal of Biomedical Research and Clinical Investigation', 'container-title-short': 'J. biomed. res. clin. investig.', 'content-domain': {'crossmark-restriction': False, 'domain': []}, 'created': {'date-parts': [[2021, 3, 19]], 'date-time': '2021-03-19T00:11:45Z', 'timestamp': 1616112705000}, 'deposited': { 'date-parts': [[2021, 4, 1]], 'date-time': '2021-04-01T19:36:15Z', 'timestamp': 1617305775000}, 'indexed': {'date-parts': [[2022, 7, 6]], 'date-time': '2022-07-06T08:28:38Z', 'timestamp': 1657096118430}, 'is-referenced-by-count': 1, 'issue': '1', 'issued': {'date-parts': [[2021, 3, 18]]}, 'journal-issue': { 'issue': '1', 'published-online': {'date-parts': [[2021, 3, 18]]}, 'published-print': {'date-parts': [[2021, 3, 18]]}}, 'link': [ { 'URL': 'https://medicalpressopenaccess.com/upload/1616111435_1008.pdf', 'content-type': 'unspecified', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'member': '16574', 'original-title': [], 'prefix': '10.31546', 'published': {'date-parts': [[2021, 3, 18]]}, 'published-online': {'date-parts': [[2021, 3, 18]]}, 'published-print': {'date-parts': [[2021, 3, 18]]}, 'publisher': 'Medical Press Open Access', 'reference-count': 0, 'references-count': 0, 'relation': {}, 'resource': {'primary': {'URL': 'https://www.medicalpressopenaccess.com/upload/1617238288_1008.pdf'}}, 'score': 1, 'short-title': [], 'source': 'Crossref', 'subject': [], 'subtitle': [], 'title': 'Ivermectin IN Long-Covid Patients: A Retrospective Study', 'type': 'journal-article', 'volume': '2'}
Late treatment
is less effective
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit